ID
15569
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Baseline: Repitition of Assessments If already performed at screening, please enter results of screening MRI.
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (3)
- 6/3/16 6/3/16 -
- 6/3/16 6/3/16 -
- 6/3/16 6/3/16 -
Uploaded on
June 3, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
Similar models
Baseline: Repitition of Assessments: MRI Multiple Sclerosis ALAIN01 NCT02419378
C0011008 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C0032976 (UMLS CUI [1,2])
C1550373 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,2])
C1274040 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C0392360 (UMLS CUI [1,2])
C1333400 (UMLS CUI [1,2])
C2700066 (UMLS CUI [1,2])
C2700066 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C2697938 (UMLS CUI [1,2])
C2697938 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])